Opportunity ID: 280505

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-16-006
Funding Opportunity Title: U.S.-China Program for Biomedical Collaborative Research (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 11, 2015
Last Updated Date:
Original Closing Date for Applications: Mar 17, 2016
Current Closing Date for Applications: Mar 17, 2016
Archive Date: Apr 17, 2016
Estimated Total Program Funding: $3,600,000
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Independent school districts
State governments
Special district governments
Public housing authorities/Indian housing authorities
Private institutions of higher education
City or township governments
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Chinese researchers in the areas of allergy, immunology, and infectious diseases including HIV/AIDS and its co-morbidities and co-infections, mental health, and selected neurological disorders.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-006.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00220067 Feb 17, 2016 Mar 17, 2016 View

Package 1

Mandatory forms

280505 RR_SF424_2_0-2.0.pdf

280505 PHS398_ResearchPlan_2_0-2.0.pdf

280505 PHS398_CoverPageSupplement_2_0-2.0.pdf

280505 RR_KeyPersonExpanded_2_0-2.0.pdf

280505 RR_OtherProjectInfo_1_3-1.3.pdf

280505 PerformanceSite_2_0-2.0.pdf

Optional forms

280505 RR_SubawardBudget30_1_3-1.3.pdf

280505 PlannedReport-1.0.pdf

280505 PHS398_CumulativeInclusionReport-1.0.pdf

280505 PHS398_ModularBudget_1_2-1.2.pdf

280505 RR_Budget_1_3-1.3.pdf

2025-07-09T20:04:15-05:00

Share This Post, Choose Your Platform!

About the Author: